China's gaming regulator approves 183 domestic games and 12 imported games in October (prev. 206 total in September)
Newsquawk Staff ·
China's gaming regulator approves 183 domestic games and 12 imported games in October (prev. 206 total in September)
What it means
Monthly approval batches from the Chinese gaming regulator have been the standing cadence since the licensing freeze ended, and the read-through has never been the absolute number so much as the continuity: steady issuance signals the post-crackdown normalisation is intact, while a skipped or sharply smaller batch has historically been taken as a quiet warning. This batch sits within the range of what the market has come to treat as routine, with the imported-game approvals the more sensitive component, since foreign titles have at times been throttled or delayed as a pressure point in the broader regulatory and geopolitical relationship. The channel is concentrated in the listed domestic publishers and the platforms that distribute imported titles, where license flow maps directly into release pipelines and revenue visibility. A domestic-heavy split with thin imported approvals, as here, modestly favours the local developers over foreign licensors and their Chinese publishing partners. What tends to matter next is whether any marquee titles are in the batch, whether imported approvals keep arriving at all, and any accompanying commentary from the regulator on content rules, which on past occasions has moved the sector more than the headline count itself. Absent a break in cadence, single-batch variation of this size has not historically been a sector-level catalyst.
- BYD Electronic (0285 HK) 9-month 2026 (RMB): net profit -69.3% Y/Y to CNY 963mln, revenue +3.38% Y/Y 127.46bln
- OpenAI’s Astra model becomes top distillation target for China’s AI labs, while Moonshot AI and DeepSeek utilise OpenAI’s Astra outputs for new models released this month, according to The Information
- Silicon Motion (SIMO) Q3 (USD) EPS 4.35 (exp. 3.30), rev. 560mln (exp. 533mln)
- Deutsche Telekom (DTE GY) is backing off on a merger with T-Mobile US (TMUS), according to reports
- Genmab (GMAB/GMAB DC) announced positive topline results from the global Phase 3 LiGeR-HN1 trial evaluating petosemtamab
Related headlines
- Eli Lilly’s (LLY) retatrutide delivered greater A1C reduction and more than double the weight loss of Novo Nordisk’s (NOVOB DC) Ozempic at its highest approved dose in head-to-head trial23 hours ago
- TPG pursues USD 5bln acquisition of UK data centre group Ark, according to FT1 day ago
- Syngenta targets at least a USD 66bln valuation in Hong Kong IPO1 day ago
- HP (HPQ), Asus (2357 TT) and Acer (2353 TT) are shifting some PC production from Thailand and Vietnam back to China to combat soaring component costs driven by AI-related memory and storage shortages, reports Nikkei citing sources1 day ago
- Universal Music Group (UMG NA) discusses going private with buyout firms, according to Bloomberg2 days ago
- Japan's Sakana AI to build homegrown model to cut US and China reliance, reports Nikkei2 days ago
- Japan's Sakana AI to build homegrown model to cut US and China reliance, Nikkei reports2 days ago
- Foxconn (2317 TT) has brought online an AI factory powered by an NVIDIA (NVDA) DGX supercomputing cluster3 days ago
- US FDA has approved Novo's (NOVOB DC) once-weekly insulin treatment for paediatric patients with type 2 diabetes mellitus5 days ago
- Meta's (META) Muse AI to counter China models with subscribers, not ads, Nikkei reports5 days ago
- Toyota (TM) to recall 68k late model 2022-2024 Lexus NX vehicles in the US due to a display flaw5 days ago
- Genmab (GMAB) Phase 3 Rina data in ovarian cancer shows PFS and OS endpoints were met5 days ago
- TikTok’s US entity is reportedly exploring deals to secure multiple gigawatts of computing capacity over the coming years, according to CNBC5 days ago
- Infosys (INFY) Q2 2026 (INR): Net profit 78.2bln (exp. 79.3bln ), revenue 492.4bln (exp. 491.3bln); lowers FY27 revenue view5 days ago
- Anthropic and Hg have agreed to form an independent consultancy Co. targeting corporate clients, FT reports citing sources6 days ago